Report: Boston Scientific Issues Alert on Its Lead-Free S-ICD Defibrillator

Fri, 03/08/2013 - 1:43pm
Mass Device

Boston Scientific warns physicians of a potential defect in its unique subcutaneous implantable cardioverter defibrillators.

Boston Scientific's Camer Health S-ICD

Boston Scientific (NYSE:BSX) recently issued a warning on its lead-free implantable defibrillators over concerns that a fuse malfunction could prevent the devices from delivering life-savings shocks, the company confirmed with today.

The company has received reports of 4 instances in which a fuse inside the subcutaneous ICD was activated inappropriately, which could cause the devices to fail. No adverse events have yet been reported, according to Boston Scientific.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.